Jul. 8 at 11:22 AM
Canaccord Genuity reiterated
$APGE Buy-
$89 and said, they believe there is a high likelihood of success for the 52-week read-out to demonstrate effective quarterly to even semi-annual dosing:
$REGN SNY
$LLY $CRVS $NKTR
Jefferies⬆️
$APGE PT to
$96 from
$88, reit'd Buy, plus⬆️risk-adj peak sales for mono to
$1.45B after APG777's Ph.2a efficacy hit its base case:
Canaccord Genuity & Jefferies said in their notes to investors:
